Form D · Biotechnology

DesiCorp, Inc.

Louisville, KY · CIK 0001997477

Offering snapshot reported Jun 9, 2026 · SEC filing

Reported sold: $3.5M
Investors reported: 12
Minimum accepted: $0
First sale: Mar 20, 2026

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$839,993 → $3,499,999
Reported investors8 → 12

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 9, 2026	Amendment	$3,499,999	$2,660,006vs Apr 1, 2026	12	SEC filing
Apr 1, 2026	Initial	$839,993	No comparison	8	SEC filing
Jan 20, 2026	Amendment	$5,188,530	$1,000,001vs Nov 14, 2025	15	SEC filing
Nov 14, 2025	Amendment	$4,188,529	$3,188,529vs Jul 18, 2024	15	SEC filing
Jul 18, 2024	Initial	$1,000,000	No comparison	5	SEC filing

Offering details

Securities: Equity, Option to acquire
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-578747

Source: Form D, filed Jun 9, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Brett Janis	Director, Executive
Jonathan Kopecheck	Director, Executive
Michael Menze	Director, Executive
Robert Saunders	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

201 E. Jefferson Street
Louisville, KY, 40202